DAVID WINCHELL: Open Payments
NPI 1871550921 · SAINT PETERS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,947 in 160 payments from 21 companies in 2025. Trend: 2023 $3,188 · 2024 $3,800 · 2025 $2,947
Food & beverage: $2,947
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 22 | $468 |
| ABBVIE INC. | 28 | $367 |
| Janssen Biotech, Inc. | 31 | $358 |
| Amgen Inc. | 15 | $314 |
| Organon LLC | 6 | $193 |
| GENZYME CORPORATION | 5 | $190 |
| E.R. Squibb & Sons, L.L.C. | 13 | $149 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $137 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $118 |
| LEO Pharma Inc. | 4 | $106 |
Products named: NEMLUVIO, TREMFYA, OTEZLA, DUPIXENT, SKYRIZI, VTAMA, RINVOQ, Sotyktu.
Industry payments across MO — which companies pay providers there.
